These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19087729)

  • 1. [Treatment of chronic hepatitis B].
    Clausen MR
    Ugeskr Laeger; 2008 Nov; 170(48):3934. PubMed ID: 19087729
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic hepatitis B. Tenofovir--the right choice from the beginning].
    MMW Fortschr Med; 2008 May; 150(21):42-3. PubMed ID: 18575255
    [No Abstract]   [Full Text] [Related]  

  • 3. Europe extends Viread indication for chronic hepatitis B.
    AIDS Patient Care STDS; 2008 Apr; 22(4):350. PubMed ID: 18434949
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].
    MMW Fortschr Med; 2009 May; 151(22):38-9. PubMed ID: 19526965
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic hepatitis B: back to the future with HBsAg.
    Moucari R; Lada O; Marcellin P
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):633-6. PubMed ID: 19681689
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B surface antigen clearance in lamivudine-treated patients: main therapeutic goal?
    Santantonio T; Fasano M; Palattella S; Pastore G
    Gastroenterology; 2007 Jun; 132(7):2617; author reply 2617-8. PubMed ID: 17570240
    [No Abstract]   [Full Text] [Related]  

  • 7. Regression of cirrhosis of the liver detected by elastiometry.
    Mössner BK; Biagini M; Pedersen C; Christensen PB
    Scand J Gastroenterol; 2008; 43(11):1401-2. PubMed ID: 18615357
    [No Abstract]   [Full Text] [Related]  

  • 8. Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity.
    Prescrire Int; 2009 Jun; 18(101):116. PubMed ID: 19637428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lamivudine treatment of a HBs antigen positive man with reactive arthritis].
    Borup C; Siboni A
    Ugeskr Laeger; 2008 Nov; 170(48):3940-1. PubMed ID: 19087731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A call for attention and trials on hepatitis B e antigen-negative, alanine aminotransferase-normal chronic hepatitis B virus infection.
    Zhao H; Miao R
    Hepatology; 2009 Aug; 50(2):658; author reply 658-9. PubMed ID: 19585650
    [No Abstract]   [Full Text] [Related]  

  • 11. [A primer on the management of antiviral resistance in chronic hepatitis B].
    Doerig C; Sahli R; Telenti A; Moradpour D
    Rev Med Suisse; 2009 Jan; 5(187):203-4, 206-8,. PubMed ID: 19271431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV Chronic hepatitis during chemotherapy - an immune controlled disease.
    Caruntu FA; Gheorghita V
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):445-9. PubMed ID: 19104707
    [No Abstract]   [Full Text] [Related]  

  • 13. [Focusing on antiviral options for the treatment of chronic hepatitis B].
    Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):321-2. PubMed ID: 16732902
    [No Abstract]   [Full Text] [Related]  

  • 14. Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B.
    Borgniet O; Parvaz P; Bouix C; Chevallier P; Trépo C; André P; Zoulim F
    J Med Virol; 2009 Aug; 81(8):1336-42. PubMed ID: 19551826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [More research needed on antiviral treatment for chronic hepatitis B].
    Ren H; Zhang DF
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):321-2. PubMed ID: 18510840
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinilal study of medical ozone therapy in chronic hepatitis B of 20 patients].
    Jiao XJ; Peng X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):484-5. PubMed ID: 19544653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility.
    Liu Y; Wang CM; Cheng J; Liang ZL; Zhong YW; Ren XQ; Xu ZH; Zoulim F; Xu DP
    Chin Med J (Engl); 2009 Jul; 122(13):1585-6. PubMed ID: 19719953
    [No Abstract]   [Full Text] [Related]  

  • 18. Wider indications for treatment of chronic hepatitis B?
    Lindh M; Hellstrand K; Norkrans G
    J Viral Hepat; 2008 Mar; 15(3):237. PubMed ID: 18086179
    [No Abstract]   [Full Text] [Related]  

  • 19. Revisiting the treatment recommendations for chronic hepatitis B.
    Chan HL
    Hepatology; 2009 Feb; 49(2):700; author reply 701-2. PubMed ID: 19177582
    [No Abstract]   [Full Text] [Related]  

  • 20. Do guidelines preclude hepatitis B patients from receiving treatment?
    Degertekin B; Lok AS
    Hepatology; 2009 Feb; 49(2):700-1; author reply 701-2. PubMed ID: 19177583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.